Muutke küpsiste eelistusi

E-raamat: Molecular Diagnostics of Cancer

  • Formaat: PDF+DRM
  • Ilmumisaeg: 06-Dec-2012
  • Kirjastus: Springer-Verlag Berlin and Heidelberg GmbH & Co. K
  • Keel: eng
  • ISBN-13: 9783642775215
  • Formaat - PDF+DRM
  • Hind: 55,56 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Lisa ostukorvi
  • Lisa soovinimekirja
  • See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.
  • Formaat: PDF+DRM
  • Ilmumisaeg: 06-Dec-2012
  • Kirjastus: Springer-Verlag Berlin and Heidelberg GmbH & Co. K
  • Keel: eng
  • ISBN-13: 9783642775215

DRM piirangud

  • Kopeerimine (copy/paste):

    ei ole lubatud

  • Printimine:

    ei ole lubatud

  • Kasutamine:

    Digitaalõiguste kaitse (DRM)
    Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale  Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

    Vajalik tarkvara
    Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

    PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

    Seda e-raamatut ei saa lugeda Amazon Kindle's. 

Present and potential future applications of new diagnostic strategies basedon the direct or indirect detection of cancer genes are delineated in this volume. Among the methodological aspects covered are enzymatic target amplification by the polymerase chain reaction and related techniques, DNA fingerprinting, transfer of putative cancer genes in appropriate receipient cells, and recent developments inthe application of monoclonal antibodies in immunohistochemistry and immunoscintigraphy. The diagnostic and functional implications of mutations in cancer genes such as ras and p53 are described. The characterization of cancer genes and their products is correlated with growth control anddissemination of tumour cells by in vitro or clinical evidence. The contributions in the present volume uptdate the information available on established or newly described cancer genes, and may help manage the transition from basic research to clinical practice.

Muu info

Springer Book Archives
The Polymerase Chain Reaction: Methodology and Diagnostic Potential.-
Gene Loss as Marker in Tumor Development: Considerations on the Origin of
Specific Brain Tumors Due to Combinant Loss of Function Mutations of Tumor
Suppressor Genes.- p53: Oncogene, Tumor Suppressor, or Both?.- Tumor Genome
Screening by Multilocus DNA Fingerprints as Obtained by Simple Repetitive
Oligonucleotide Probes.- Activation of ras Oncogenes in Human Tumours.-
Laboratory Techniques in the Investigation of Human Papillomavirus
Infection.- Detection of Minimal Residual Leukemia by Polymerase Chain
Reactions.- A Dominant Metastogene Confers Metastatic Potential to Tumor
Cells.- Progression in Human Melanoma Is Accompanied by the Altered
Expression of Cell Adhesion Molecules.- Structure, Function and Expression of
the CEA Gene Family: Diagnostic and Therapeutic Implications.- Membrane
Proteins as Markers for Normal and Neoplastic Endocrine Cells.- Biological
and Clinical Relevance of the Tumor-Associated Serine Protease uPA.- Analysis
of Growth Regulatory Pathways in Human Neuro-Oncology.- HER-2/Neu/c-ERB-B2
Amplification: Clinical Relevance in Mammary Carcinoma.- Cytokine-Mediated
Regulation of Growth Factor Receptors (EGF-R and erb-B2) in Pancreatic
Tumors.- Chimeric CEA-Specific Antibody Fragments and Anti-idiotypic
Antibodies for Immunoscintigraphy and New Therapeutic Approaches to
Colorectal Carcinomas.- Tumor Localization by Immunoscintigraphy: Potential
and Limitations.